Skip to main content

Table 2 Metabolites detected by LC-Q-TOF–MS in the validation sample set (HTN-PDS patients with body mass index from normal to high (N–H))/high to normal (H-N)) and their biological variation

From: Weight changes in hypertensive patients with phlegm-dampness syndrome: an integrated proteomics and metabolomics approach

Rt

Mass

Name

Formula

Folder

RV

Hypertensive patients with BMI from normal to high (N–H)

 883.853

923.7343

PC(22:2(13Z,16Z)/24:1(15Z))

C54H102NO8P

− 4.2589

0.30

 488.784

493.3168

LysoPC(16:1(9Z))

C24H48NO7P

− 1.3129

0.20

 502.977

520.2719

Dolichyl diphosphate

C25H46O7P2

1.1990

0.10

 515.839

761.4996

PE(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

C43H72NO8P

1.7277

0.10

 275.788

491.0008

dATP

C10H16N5O12P3

− 1.3376

0.08

 863.462

858.5258

PI(16:0/20:4(5Z,8Z,11Z,14Z))

C45H79O13P

5.7789

0.06

 868.575

858.5692

All-trans-Decaprenyl diphosphate

C50H84O7P2

5.7789

0.02

 256.068

432.066

Se-Adenosylselenohomocysteine

C14H20N6O5Se

1.0574

0.02

 1170.565

412.0185

dIDP

C10H14N4O10P2

− 2.4528

0.01

 277.447

482.9845

Cytidine triphosphate (CTP)

C9H16N3O14P3

1.2429

0.01

Hypertensive patients with BMI from high to normal (H-N)

 1141.523

705.5309

PC(14:0/16:0)

C38H76NO8P

6.4684

0.32

 652.833

420.3603

3b,5a,6b-Cholestanetriol

C27H48O3

− 7.4571

0.16

 521.412

722.444

Octaprenyl diphosphate

C40H68O7P2

2.4689

0.12

 190.274

141.0426

2-aminomuconic acid semialdehyde

C6H7NO3

− 4.6339

0.10

 61.626

129.0426

Pyroglutamic acid

C5H7NO3

6.5815

0.08

 223.019

189.0637

N-Acetyl-L-glutamic acid

C7H11NO5

3.2199

0.06

 324.918

462.2618

Retinyl beta-glucuronide

C26H38O7

4.5571

0.05

 89.597

168.0283

Uric acid

C5H4N4O3

− 1.7995

0.03

 864.632

130.063

3-Methyl-2-oxovaleric acid

C6H10O3

3.3563

0.02

 190.188

175.0633

3-Indoleacetic Acid

C10H9NO2

− 1.0880

0.02

 66.389

190.0114

Oxalosuccinic acid

C6H6O7

− 3.0817

0.02

 51.332

339.0468

5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate

C9H14N3O9P

− 13.5318

0.01

 63.879

112.016

2-Furoic acid

C5H4O3

− 2.4225

0.01

 625.18

362.2093

18-Hydroxycorticosterone

C21H30O5

3.9819

0.01

  1. “Folder” refers to the “normal BMI vs. high BMI” change value; RV is the power of the metabolite to reflect the abnormal state in the disease
  2. LysoPC: Lysophosphatidylcholine; PC: Phosphatidylcholine